Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orthokine versus PRP for knee osteoarthritis pain
IRCT20260805070539N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2024
- Countries
- 1
01
Overview
Phase 3, double-blind trial of autologous conditioned serum and platelet-rich plasma in osteoarthritis (OA) and knee osteoarthritis (OA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain severity score and Functional status. Started Sep 2024; status: completed.
02
Drugs
autologous conditioned serumplatelet-rich plasma
03
Conditions
osteoarthritis (OA)knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20260805070539N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260805070539N1.